Startup Fundraisingβ€’

Paine Schwartz Invests in Family Wellness Brand First Day

Paine Schwartz Partners backs First Day Life, Inc., a fast-growing family wellness brand, to expand its science-informed, clean-label supplement offerings.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Consumer, Healthcare, Healthtech & Medtech in United States" are published.

Key Takeaways

  • First Day Life, Inc. raised a new round from Paine Schwartz Partners.
  • Sector: Consumer, Healthcare, Healthtech & Medtech.
  • Geography: United States.

Analysis

Paine Schwartz Partners, a prominent private equity firm with a dedicated focus on the food chain, has injected capital into First Day Life, Inc., a rapidly expanding company specializing in family-oriented wellness products. This strategic move underscores Paine Schwartz's commitment to the health and wellness sector, a core tenet of its investment strategy. The firm's existing portfolio includes other 'better-for-you' brands such as Suja Life and Promix, indicating a clear pattern of backing companies that cater to evolving consumer demands for healthier options.

First Day, headquartered in Austin, Texas, has carved out a niche by offering clean-label vitamins, minerals, and supplements formulated with scientific backing for the entire family. Since its inception in 2019, the company has achieved significant traction, distributing over half a billion gummies. Its product range features high-absorption formulations for multivitamins, magnesium, probiotics, and cognitive support, available through direct-to-consumer channels, Amazon, and traditional retail outlets. This multi-channel approach has been instrumental in reaching millions of households seeking accessible health solutions.

The investment, finalized through Paine Schwartz Food Chain Fund VI, will support First Day's continued expansion. Founder and CEO Alice Li will remain at the helm, steering the company's vision. Li expressed enthusiasm for the partnership, highlighting Paine Schwartz's understanding of their mission to make clinical science accessible through effective products. She emphasized the firm's expertise in scaling consumer brands and their shared conviction in building a leading omnichannel family health brand that serves consumers across all life stages and purchasing preferences.

Kevin Schwartz, CEO of Paine Schwartz, commented on the alignment of First Day with the firm's investment thesis. He noted the company's impressive capital efficiency and the trust it has garnered from over one million families. The wellness supplement market, a segment within the broader health and wellness industry valued at tens of billions globally and experiencing consistent annual growth, is increasingly driven by consumer scrutiny of ingredient quality and product efficacy. First Day's 'No Junk' commitment, which excludes artificial ingredients and fillers, resonates strongly in this environment.

This transaction represents a significant development for First Day as it enters its next growth phase. The partnership with Paine Schwartz is expected to provide the strategic guidance and financial resources necessary to further solidify its market position. The company's focus on science-informed, clean-label products for families addresses a growing demographic seeking preventative health solutions and nutritional support for all ages, from children to adults.

While financial specifics of the deal were not disclosed, the collaboration signifies a strong vote of confidence in First Day's business model and its potential within the competitive health and wellness consumer goods sector. The company's success in rapidly scaling its operations since 2019, coupled with its commitment to transparency and efficacy, positions it well for future advancements in product development and market penetration.